Southern Research offers a robust platform for evaluating immunotherapies through integrated preclinical capabilities that span molecular profiling, immune cell characterization, and in vivo efficacy modeling. Leveraging advanced flow cytometry, multiplex cytokine analysis, and syngeneic and humanized mouse models, the institute provides comprehensive assessment of immune-modulating agents across solid and hematologic malignancies. Its interdisciplinary team supports biomarker-driven insights and mechanistic studies to optimize therapeutic strategies. With expertise in tumor immunology, immune-oncology combinations, and translational research, Southern Research enables accelerated development of immunotherapies from discovery through IND-enabling studies, offering industry partners a high-impact environment for advancing immune-targeted cancer treatments.